At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
HistoSonics Investigational Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy
In Brief
A clinical study evaluating HistoSonics Investigational System for Renal Cancer and 5 related conditions. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of this trial is to evaluate the technical success and safety profile of the HistoSonics Investigational System for the treatment of primary solid renal tumors.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRenal Cancer, Tumor, Solid, Kidney Cancer, Tumor, Tumor, Benign, Kidney Neoplasms
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedJun 2022
Enrollment StartMar 2023
Primary CompletionDec 2024
Study CompletionJun 2025
TodayJul 2026
First PostedJun 27, 2022
Enrollment StartMar 23, 2023
Primary CompletionDec 28, 2024
Study CompletionJun 6, 2025
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 4.0 years ago
Interventions
HistoSonics Investigational Systemdevice
The HistoSonics Investigational System is intended for the non-invasive destruction of kidney tissue using histotripsy, a non-thermal mechanical process of focused ultrasound.